• <code id="ossuk"></code>
    • <li id="ossuk"></li>
    • <rt id="ossuk"></rt>
    • <rt id="ossuk"><tr id="ossuk"></tr></rt>
      <abbr id="ossuk"></abbr>
      <rt id="ossuk"><acronym id="ossuk"></acronym></rt>
      產品中心您現在的位置:首頁 > 產品展示 > > 天然免疫研究產品 > LPS-EB Ultrapure

      LPS-EB Ultrapure

      更新時間:2022-01-29

      簡要描述:

      LPS is the principal component of Gram-negative bacteria that activates the innate immune system through its recognition by Toll-like receptor 4 (TLR4). This leads to a signaling cascade that ultimat…

      型號:廠商性質:代理商瀏覽量:803

      Lipopolysaccharide from Escherichia coli 0111:B4

      LPS is the principal component of Gram-negative bacteria that activates the innate immune system through its recognition by Toll-like receptor 4 (TLR4). This leads to a signaling cascade that ultimately results in the activation of NF-κB and the production of proinflammatory cytokines [1]. LPS-EB is a preparation of smooth (S)-form LPS purified from the Gram-negative E. coli 0111:B4, a pathogenic serotype of E. coli known to cause significant gastric disease [2,3].

       

      InvivoGen provides LPS-EB with two grades of purity:

      • LPS-EB is a standard lipopolysaccharide (LPS) preparation extracted by a phenol-water mixture. LPS-EB contains other bacterial components, such as lipoproteins, and therefore stimulates both TLR4 and TLR2.

      • LPS-EB Ultrapure is extracted by successive enzymatic hydrolysis steps and purified by the previously described phenol-TEA-DOC extraction protocol [4]. This process removes contaminating lipoproteins, and therefore LPS-EB Ultrapure only activates TLR4. 

       

      References:

      1. Kuzmich, N.N. et al., 2017. TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis. Vaccines (Basel) 5unol. 165(2):618-22.
      2. Coleman, W.G., Jr. et al., 1977. Genetic analysis of Escherichia coli O111:B4, a strain of medical and biochemical interest. J Bacteriol 130, 656-660.
      3. Viljanen, M.K. et al., 1990. Outbreak of diarrhea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet 336, 831-834.
      4. Hirschfeld M. et al., 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol. 165(2):618-22.

       

      Specifications

      LPS-EB

      Specificity: TLR4 and TLR2 agonist.

      Solubility: 5 mg/ml in water.

      Working concentration: 10 ng - 10 µg/ml.

      LPS-EB Ultrapure

      Specificity: TLR4 agonist.

      Solubility: 5  x 10e6 EU/ml in water.

      Working concentration: 10e1 - 10e4 EU/ml.


      Contents

      LPS-EB

      • 5 mg lipopolysaccharide from E. coli 0111:B4 (LPS-EB ).

      • 1.5 ml endotoxin-free water.

      LPS-EB Ultrapure

      • 5 x 106 EU  ultrapure lipopolysaccharide from E. coli 0111:B4 (LPS-EB Ultrapure).

      • 1.5 ml endotoxin-free water.

       

       Products are shipped at room temperature.

       Upon receipt product should be stored at -20°C.

       Lyophilized product is stable 1 year at -20°C.

      Resuspended product is stable 1 month at 4°C and 6 months at -20°C.


      如需購買或咨詢該產品技術問題,請聯系Invivogen一級代理商--欣博盛生物

      留言框

      • 產品:

      • 您的單位:

      • 您的姓名:

      • 聯系電話:

      • 常用郵箱:

      • 省份:

      • 詳細地址:

      • 補充說明:

      • 驗證碼:

        請輸入計算結果(填寫阿拉伯數字),如:三加四=7

      上一篇:LPS-EK

      下一篇:LPS-EB

      返回列表>>
      久久99热66这里只有精品一| 国产999精品久久久久久| 久久久国产精品网站| 亚洲欧美日韩综合久久久| 久久伊人精品热在75| 国产精品丝袜久久久久久不卡 | 久久夜色精品国产亚洲av| 久久人人青草97香蕉| 久久国产中文字幕| 亚洲中文字幕无码久久2017| 国产精品久久久久久久福利院| 久久精品国产亚洲AV久| 久久久久成人精品一区二区| 久久无码一区二区三区少妇| 日本精品久久久久护士| 2021久久精品国产99国产精品| 久久777国产线看观看精品卜| 国产亚洲美女精品久久久久狼| 亚洲欧洲精品成人久久奇米网 | 丁香狠狠色婷婷久久综合| 2021久久精品国产99国产精品| 人妻无码久久一区二区三区免费 | 亚洲中文字幕无码久久| 久久精品无码午夜福利理论片| 国产成人久久精品激情| 久久久青草青青国产亚洲免观| 国产69久久精品成人看小说| 一本天堂ⅴ无码亚洲道久久| 久久久久久久精品妇女99| 伊人丁香狠狠色综合久久| 久久精品影院永久网址| 亚洲中文久久精品无码ww16| 老色鬼久久综合第一| 久久精品国产福利国产琪琪| 国产成人无码精品久久久露脸 | 久久精品网站免费观看| AV无码久久久久不卡网站下载| 久久99精品久久久久婷婷| 伊人丁香狠狠色综合久久| 老色鬼久久亚洲AV综合| 少妇高潮惨叫久久久久久|